CN111218506B - 一种smn1和smn2基因拷贝数的检测试剂盒 - Google Patents
一种smn1和smn2基因拷贝数的检测试剂盒 Download PDFInfo
- Publication number
- CN111218506B CN111218506B CN202010138478.6A CN202010138478A CN111218506B CN 111218506 B CN111218506 B CN 111218506B CN 202010138478 A CN202010138478 A CN 202010138478A CN 111218506 B CN111218506 B CN 111218506B
- Authority
- CN
- China
- Prior art keywords
- primer
- smn1
- smn2
- exon
- human genome
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 102100021947 Survival motor neuron protein Human genes 0.000 title claims abstract description 189
- 101000617738 Homo sapiens Survival motor neuron protein Proteins 0.000 title claims abstract description 180
- 238000001514 detection method Methods 0.000 title claims abstract description 57
- 238000006243 chemical reaction Methods 0.000 claims abstract description 36
- 101150081851 SMN1 gene Proteins 0.000 claims abstract description 17
- 101150015954 SMN2 gene Proteins 0.000 claims abstract description 14
- 238000000034 method Methods 0.000 claims abstract description 13
- 108700039887 Essential Genes Proteins 0.000 claims abstract description 8
- 238000005251 capillar electrophoresis Methods 0.000 claims abstract description 7
- 208000002320 spinal muscular atrophy Diseases 0.000 claims description 51
- 108020004414 DNA Proteins 0.000 claims description 32
- 238000012408 PCR amplification Methods 0.000 claims description 25
- 108090000623 proteins and genes Proteins 0.000 claims description 21
- 108700024394 Exon Proteins 0.000 claims description 16
- 239000012634 fragment Substances 0.000 claims description 14
- 238000004458 analytical method Methods 0.000 claims description 11
- 108020004707 nucleic acids Proteins 0.000 claims description 10
- 102000039446 nucleic acids Human genes 0.000 claims description 10
- 150000007523 nucleic acids Chemical class 0.000 claims description 10
- 101000899111 Homo sapiens Hemoglobin subunit beta Proteins 0.000 claims description 9
- 239000013612 plasmid Substances 0.000 claims description 8
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 6
- 239000012295 chemical reaction liquid Substances 0.000 claims description 6
- 238000011144 upstream manufacturing Methods 0.000 claims description 6
- 239000007788 liquid Substances 0.000 claims description 5
- 238000002360 preparation method Methods 0.000 claims description 5
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 claims description 4
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 claims description 4
- 101000756632 Homo sapiens Actin, cytoplasmic 1 Proteins 0.000 claims description 4
- 239000003623 enhancer Substances 0.000 claims description 4
- 239000000203 mixture Substances 0.000 claims description 4
- 238000004364 calculation method Methods 0.000 claims description 3
- 239000007850 fluorescent dye Substances 0.000 claims description 3
- KWIUHFFTVRNATP-UHFFFAOYSA-N Betaine Natural products C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 claims description 2
- 102000016928 DNA-directed DNA polymerase Human genes 0.000 claims description 2
- 108010014303 DNA-directed DNA polymerase Proteins 0.000 claims description 2
- 102100031181 Glyceraldehyde-3-phosphate dehydrogenase Human genes 0.000 claims description 2
- KWIUHFFTVRNATP-UHFFFAOYSA-O N,N,N-trimethylglycinium Chemical compound C[N+](C)(C)CC(O)=O KWIUHFFTVRNATP-UHFFFAOYSA-O 0.000 claims description 2
- 229960003237 betaine Drugs 0.000 claims description 2
- 108020004445 glyceraldehyde-3-phosphate dehydrogenase Proteins 0.000 claims description 2
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 claims description 2
- 108010079245 Cystic Fibrosis Transmembrane Conductance Regulator Proteins 0.000 claims 1
- 101000899492 Parthenium argentatum Allene oxide synthase Proteins 0.000 claims 1
- 238000003745 diagnosis Methods 0.000 abstract description 5
- 239000000969 carrier Substances 0.000 abstract description 4
- 230000008569 process Effects 0.000 abstract description 3
- 238000002474 experimental method Methods 0.000 abstract description 2
- 238000012544 monitoring process Methods 0.000 abstract description 2
- 208000022074 proximal spinal muscular atrophy Diseases 0.000 abstract 2
- 239000000523 sample Substances 0.000 description 23
- 230000003321 amplification Effects 0.000 description 21
- 238000003199 nucleic acid amplification method Methods 0.000 description 21
- 239000003153 chemical reaction reagent Substances 0.000 description 17
- 238000012217 deletion Methods 0.000 description 11
- 230000037430 deletion Effects 0.000 description 11
- 201000010099 disease Diseases 0.000 description 10
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 10
- 230000035772 mutation Effects 0.000 description 10
- 239000000243 solution Substances 0.000 description 7
- 238000012360 testing method Methods 0.000 description 6
- 101150044182 8 gene Proteins 0.000 description 5
- 239000013558 reference substance Substances 0.000 description 5
- 101150113275 Smn gene Proteins 0.000 description 4
- 238000005516 engineering process Methods 0.000 description 4
- 108090000790 Enzymes Proteins 0.000 description 3
- 102000004190 Enzymes Human genes 0.000 description 3
- 238000013461 design Methods 0.000 description 3
- 229940088598 enzyme Drugs 0.000 description 3
- 210000002161 motor neuron Anatomy 0.000 description 3
- 210000002569 neuron Anatomy 0.000 description 3
- 238000011002 quantification Methods 0.000 description 3
- 238000007894 restriction fragment length polymorphism technique Methods 0.000 description 3
- -1 wherein high Substances 0.000 description 3
- 102000053602 DNA Human genes 0.000 description 2
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 2
- ZHNUHDYFZUAESO-UHFFFAOYSA-N Formamide Chemical compound NC=O ZHNUHDYFZUAESO-UHFFFAOYSA-N 0.000 description 2
- 206010033799 Paralysis Diseases 0.000 description 2
- 238000011529 RT qPCR Methods 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 238000004128 high performance liquid chromatography Methods 0.000 description 2
- 238000002844 melting Methods 0.000 description 2
- 230000008018 melting Effects 0.000 description 2
- 239000011259 mixed solution Substances 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 238000003753 real-time PCR Methods 0.000 description 2
- 108091008146 restriction endonucleases Proteins 0.000 description 2
- 230000035945 sensitivity Effects 0.000 description 2
- 210000000278 spinal cord Anatomy 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 102100031262 Deleted in malignant brain tumors 1 protein Human genes 0.000 description 1
- 206010061818 Disease progression Diseases 0.000 description 1
- 206010064571 Gene mutation Diseases 0.000 description 1
- 108091027305 Heteroduplex Proteins 0.000 description 1
- 101000844721 Homo sapiens Deleted in malignant brain tumors 1 protein Proteins 0.000 description 1
- 101001018026 Homo sapiens Lysosomal alpha-glucosidase Proteins 0.000 description 1
- 108091092195 Intron Proteins 0.000 description 1
- 206010028372 Muscular weakness Diseases 0.000 description 1
- 206010056677 Nerve degeneration Diseases 0.000 description 1
- 208000032225 Proximal spinal muscular atrophy type 1 Diseases 0.000 description 1
- 208000033526 Proximal spinal muscular atrophy type 3 Diseases 0.000 description 1
- 208000033550 Proximal spinal muscular atrophy type 4 Diseases 0.000 description 1
- 108700005075 Regulator Genes Proteins 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- 210000000349 chromosome Anatomy 0.000 description 1
- 238000003759 clinical diagnosis Methods 0.000 description 1
- 238000012790 confirmation Methods 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000007850 degeneration Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 230000005750 disease progression Effects 0.000 description 1
- 238000001976 enzyme digestion Methods 0.000 description 1
- ZINJLDJMHCUBIP-UHFFFAOYSA-N ethametsulfuron-methyl Chemical compound CCOC1=NC(NC)=NC(NC(=O)NS(=O)(=O)C=2C(=CC=CC=2)C(=O)OC)=N1 ZINJLDJMHCUBIP-UHFFFAOYSA-N 0.000 description 1
- 230000008014 freezing Effects 0.000 description 1
- 238000007710 freezing Methods 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 102000045921 human GAA Human genes 0.000 description 1
- 230000008676 import Effects 0.000 description 1
- 201000006913 intermediate spinal muscular atrophy Diseases 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 238000011880 melting curve analysis Methods 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 238000001964 muscle biopsy Methods 0.000 description 1
- 201000000585 muscular atrophy Diseases 0.000 description 1
- 230000036473 myasthenia Effects 0.000 description 1
- 229940103023 myozyme Drugs 0.000 description 1
- 230000004770 neurodegeneration Effects 0.000 description 1
- 230000032696 parturition Effects 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 238000007430 reference method Methods 0.000 description 1
- 230000003252 repetitive effect Effects 0.000 description 1
- 210000003019 respiratory muscle Anatomy 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 238000010257 thawing Methods 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 208000032471 type 1 spinal muscular atrophy Diseases 0.000 description 1
- 208000032527 type III spinal muscular atrophy Diseases 0.000 description 1
- 208000005606 type IV spinal muscular atrophy Diseases 0.000 description 1
- 238000010200 validation analysis Methods 0.000 description 1
- 108700026220 vif Genes Proteins 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6844—Nucleic acid amplification reactions
- C12Q1/686—Polymerase chain reaction [PCR]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/156—Polymorphic or mutational markers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/16—Primer sets for multiplex assays
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Analytical Chemistry (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- General Health & Medical Sciences (AREA)
- Immunology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Pathology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Ultra Sonic Daignosis Equipment (AREA)
- Magnetic Resonance Imaging Apparatus (AREA)
Abstract
Description
Claims (10)
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202010138478.6A CN111218506B (zh) | 2020-03-03 | 2020-03-03 | 一种smn1和smn2基因拷贝数的检测试剂盒 |
US17/151,225 US11655509B2 (en) | 2020-03-03 | 2021-01-18 | Kits for diagnosing spinal muscular atrophy and uses thereof |
TW110101769A TWI781518B (zh) | 2020-03-03 | 2021-01-18 | 用以診斷脊髓性肌肉萎縮症之套組及其用途 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202010138478.6A CN111218506B (zh) | 2020-03-03 | 2020-03-03 | 一种smn1和smn2基因拷贝数的检测试剂盒 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN111218506A CN111218506A (zh) | 2020-06-02 |
CN111218506B true CN111218506B (zh) | 2022-07-08 |
Family
ID=70808014
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202010138478.6A Active CN111218506B (zh) | 2020-03-03 | 2020-03-03 | 一种smn1和smn2基因拷贝数的检测试剂盒 |
Country Status (3)
Country | Link |
---|---|
US (1) | US11655509B2 (zh) |
CN (1) | CN111218506B (zh) |
TW (1) | TWI781518B (zh) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN112280848A (zh) * | 2020-11-04 | 2021-01-29 | 北京迈基诺基因科技股份有限公司 | 一种人运动神经元基因拷贝数相对定量检测方法及试剂盒 |
CN112280852B (zh) * | 2020-11-16 | 2022-05-10 | 浙江大学 | 一种smn1基因突变检测试剂盒及其应用 |
CN113652474B (zh) * | 2021-08-26 | 2023-09-01 | 胜亚生物科技(厦门)有限公司 | 一种dmd基因外显子拷贝数变异的检测方法及其应用 |
CN114480620B (zh) * | 2022-01-18 | 2023-09-22 | 无锡中德美联生物技术有限公司 | 联合检测人smn1和smn2基因的试剂盒及其应用 |
CN117070607A (zh) * | 2023-08-16 | 2023-11-17 | 广州凯普医药科技有限公司 | 一种检测人脊髓性肌萎缩症smn1和smn2基因拷贝数的荧光定量pcr试剂盒 |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB0604674D0 (en) * | 2006-03-08 | 2006-04-19 | Bionet Corp | Method Of Determining Suspectibility To Spinal Muscular Atrophy (SMA) And The Related Primer Pairs |
CN104630368A (zh) * | 2015-02-09 | 2015-05-20 | 上海五色石医学研究有限公司 | 一种人运动神经元基因拷贝数相对定量检测方法及试剂盒 |
CN108048548A (zh) * | 2017-11-07 | 2018-05-18 | 北京华瑞康源生物科技发展有限公司 | 人脊髓性肌萎缩症致病基因拷贝数检测荧光定量pcr试剂盒 |
CN108396060A (zh) * | 2018-03-09 | 2018-08-14 | 中南大学 | 基于实时荧光定量pcr技术的脊肌萎缩症致病基因smn1拷贝数检测试剂盒及方法 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TWI350312B (en) * | 2009-03-16 | 2011-10-11 | Univ Kaohsiung Medical | Method for determining smn gene transfer and intragenic mutations |
WO2014210199A2 (en) * | 2013-06-25 | 2014-12-31 | Carl Wittwer | Methods of performing polymerase chain reaction and related uses thereof |
US20190066842A1 (en) * | 2016-03-09 | 2019-02-28 | Baylor College Of Medicine | A novel algorithm for smn1 and smn2 copy number analysis using coverage depth data from next generation sequencing |
-
2020
- 2020-03-03 CN CN202010138478.6A patent/CN111218506B/zh active Active
-
2021
- 2021-01-18 TW TW110101769A patent/TWI781518B/zh active
- 2021-01-18 US US17/151,225 patent/US11655509B2/en active Active
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB0604674D0 (en) * | 2006-03-08 | 2006-04-19 | Bionet Corp | Method Of Determining Suspectibility To Spinal Muscular Atrophy (SMA) And The Related Primer Pairs |
CN104630368A (zh) * | 2015-02-09 | 2015-05-20 | 上海五色石医学研究有限公司 | 一种人运动神经元基因拷贝数相对定量检测方法及试剂盒 |
CN108048548A (zh) * | 2017-11-07 | 2018-05-18 | 北京华瑞康源生物科技发展有限公司 | 人脊髓性肌萎缩症致病基因拷贝数检测荧光定量pcr试剂盒 |
CN108396060A (zh) * | 2018-03-09 | 2018-08-14 | 中南大学 | 基于实时荧光定量pcr技术的脊肌萎缩症致病基因smn1拷贝数检测试剂盒及方法 |
Non-Patent Citations (1)
Title |
---|
脊髓性肌萎缩症运动神经元生存基因2拷贝数与临床表型的关系;陈万金等;《中华神经科杂志》;20051123(第11期);673-676 * |
Also Published As
Publication number | Publication date |
---|---|
US11655509B2 (en) | 2023-05-23 |
US20210277473A1 (en) | 2021-09-09 |
TW202134441A (zh) | 2021-09-16 |
CN111218506A (zh) | 2020-06-02 |
TWI781518B (zh) | 2022-10-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN111218506B (zh) | 一种smn1和smn2基因拷贝数的检测试剂盒 | |
CN112397144B (zh) | 检测基因突变及表达量的方法及装置 | |
CN110468192B (zh) | 一种检测人类脊髓性肌萎缩症基因突变的飞行时间质谱核酸分析方法 | |
CN110577987B (zh) | 一种fmr1基因cgg重复序列的检测方法及其应用 | |
CN116287192A (zh) | 一种整合smn1与smn2拷贝数、微小变异与家系连锁分析的试剂盒及其应用 | |
CN112280848A (zh) | 一种人运动神经元基因拷贝数相对定量检测方法及试剂盒 | |
CN114317728B (zh) | 用于检测sma中多种突变的引物组、试剂盒、方法和系统 | |
CN111118141A (zh) | 一种用于葡萄糖-6-磷酸脱氢酶(g6pd)基因突变检测的引物序列及试剂盒 | |
CN107236037A (zh) | 一种突变的msh6蛋白及其编码基因、应用 | |
CN110846409A (zh) | 用于检测tnni3k基因突变的引物组合及其应用 | |
CN110846408A (zh) | 用于检测ttn基因突变的引物组合及其应用 | |
CN111850116A (zh) | 一组nk/t细胞淋巴瘤的基因突变位点群、靶向测序试剂盒及应用 | |
CN116479103B (zh) | 一种检测脊髓性肌萎缩症相关基因的试剂盒 | |
CN116287198A (zh) | 一种检测多种疾病相关基因突变类型的引物组、试剂盒和方法 | |
CN112280852B (zh) | 一种smn1基因突变检测试剂盒及其应用 | |
CN116622836A (zh) | 一种用于检测β-地中海贫血基因突变的引物探针组合及其应用 | |
CN116121360A (zh) | 一种用于检测dba致病基因集合的试剂盒及检测方法 | |
CN115948531A (zh) | 一种检测非缺失型地贫的引物组、方法及其应用 | |
CN114381515A (zh) | 一种检测异常血红蛋白基因突变的试剂盒 | |
CN114196740A (zh) | 用于同时识别多种基因类型的数字扩增检测方法、检测产品和检测试剂盒 | |
CN113151428A (zh) | 一种检测文库构建过程中样本混淆的方法和装置 | |
CN113652474A (zh) | 一种dmd基因外显子拷贝数变异的检测方法及其应用 | |
CN108753970B (zh) | 无功能型垂体腺瘤检测装置和应用 | |
CN110863044A (zh) | 用于检测vcl基因突变的引物组合及其应用 | |
CN114381513B (zh) | 一种与x连锁淋巴增生症相关的生物标志物及其应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right |
Effective date of registration: 20221012 Address after: 361028 Floor 2, Building A17, Xiamen Biomedical Industrial Park, No. 2032, Wengjiao West Road, Haicang District, Xiamen, Fujian Patentee after: Xiamen baiouxun Biotechnology Co.,Ltd. Address before: 361000 Floor 4, Building A17, Xiamen Biomedical Industrial Park, No. 2032, Wengjiao West Road, Haicang District, Xiamen City, Fujian Province Patentee before: Shengya Biotechnology (Xiamen) Co.,Ltd. |
|
TR01 | Transfer of patent right | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: A detection kit for copy number of SMN1 and SMN2 genes Granted publication date: 20220708 Pledgee: Xiamen Haicang Financing Guarantee Co.,Ltd. Pledgor: Xiamen baiouxun Biotechnology Co.,Ltd. Registration number: Y2024980007552 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right |